Dyspnoea has been reported as an adverse reaction across 24 drug(s) manufactured by Haleon Us Holdings Llc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 27,655 adverse event reports mention dyspnoea in connection with Haleon Us Holdings Llc products.
This page provides a breakdown of which Haleon Us Holdings Llc drugs are most commonly associated with dyspnoea, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
Haleon Us Holdings Llc Drugs Reporting Dyspnoea
The following Haleon Us Holdings Llc drugs have dyspnoea listed in their FDA adverse event reports, sorted by report count:
Which Haleon Us Holdings Llc drugs cause Dyspnoea?
24 drug(s) manufactured by Haleon Us Holdings Llc have dyspnoea listed in their FDA adverse event reports: DICLOFENAC SODIUM, FLUTICASONE PROPIONATE, CALCIUM CARBONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, IBUPROFEN SODIUM, and others.
How many Dyspnoea reports are there for Haleon Us Holdings Llc drugs?
There are a combined 27,655 reports of dyspnoea across 24 Haleon Us Holdings Llc drug(s) in the FDA adverse event database.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.